Rock, K. L.; Gramm, C.; Rothstein, L.; Clark, K.; Stein, R.; Dick, L.; Hwang, D.; Goldberg, A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994, 78, (5), 761-771.
Kisselev, A. F.; Goldberg, A. L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 2001, 8, (8), 739-758.
Borissenko, L.; Groll, M. 20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development. Chem. Rev. (Washington, DC, U. S.) 2007, 107, (3), 687-717.
Kane, R. C.; Bross, P. F.; Farrell, A. T.; Pazdur, R. Velcade(R): U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy. Oncologist 2003, 8, (6), 508-513.
Gantt, S. M.; Myung, J. M.; Briones, M. R. S.; Li, W. D.; Corey, E. J.; Omura, S.; Nussenzweig, V.; Sinnis, P. Proteasome Inhibitors Block Development of Plasmodium spp. Antimicrob. Agents Chemother. 1998, 42, (10), 2731-2738.
Lindenthal, C.; Weich, N.; Chia, Y. S.; Heussler, V.; Klinkert, M. Q. The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites. Parasitology 2005, 131, (01), 37-44.
Hatabu, T.; Hagiwara, M.; Taguchi, N.; Kiyozawa, M.; Suzuki, M.; Kano, S.; Sato, K. Plasmodium falciparum: The fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum. Exp. Parasitol. 2006, 112, (3), 179-183.
Kreidenweiss, A.; Kremsner, P.; Mordmuller, B. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malaria Journal 2008, 7, (1), 187.
Reynolds, J.; El Bissati, K.; Brandenburg, J.; Gunzl, A.; Mamoun, C. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clinical Pharmacology 2007, 7, (1), 13.
Li, G.-D.; Li, J.-L.; Mugthin, M.; Ward, S. A. Molecular cloning of a gene encoding a 20S proteasome beta subunit from Plasmodium falciparum. Int. J. Parasitol. 2000, 30, (6), 729-733.
Ramasamy, G.; Gupta, D.; Mohmmed, A.; Chauhan, V. S. Characterization and localization of Plasmodium falciparum homolog of prokaryotic ClpQ/HslV protease. Mol. Biochem. Parasitol. 2007, 152, (2), 139-148.
Lepp, Z.; Kinoshita, T.; Chuman, H. Screening for New Antidepressant Leads of Multiple Activities by Support Vector Machines. J. Chem. Inf. Model. 2005, 46, (1), 158-167.
Han, L. Y.; Ma, X. H.; Lin, H. H.; Jia, J.; Zhu, F.; Xue, Y.; Li, Z. R.; Cao, Z. W.; Ji, Z. L.; Chen, Y. Z. A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor. J. Mol. Graphics Model. 2008, 26, (8), 1276-1286.
Ma, X. H.; Wang, R.; Yang, S. Y.; Li, Z. R.; Xue, Y.; Wei, Y. C.; Low, B. C.; Chen, Y. Z. Evaluation of Virtual Screening Performance of Support Vector Machines Trained by Sparsely Distributed Active Compounds. J. Chem. Inf. Model. 2008, 48, (6), 1227-1237.
Wang, Y.; Bolton, E.; Dracheva, S.; Karapetyan, K.; Shoemaker, B. A.; Suzek, T. O.; Wang, J.; Xiao, J.; Zhang, J.; Bryant, S. H. An overview of the PubChem BioAssay resource. Nucl. Acids Res. 38, (suppl_1), D255-266.
Ward, J. H. Hierarchical Grouping to Optimize an Objective Function. J. Am. Stat. Assoc. 1963, 58, (301), 236-244.
Kelley, L. A.; Gardner, S. P.; Sutcliffe, M. J. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. Protein Eng. 1996, 9, (11), 1063-1065.